Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
American Academy of Dermatology
Pharma
Incyte posts mixed Opzelura results in prurigo nodularis
As Incyte strives to push Opzelura into new dermatology indications, the company’s latest data drop in prurigo nodularis is a bit of a mixed bag.
Fraiser Kansteiner
Mar 10, 2025 11:23am
In year 2 under new CEO, troubled Leo Pharma makes progress
Mar 12, 2024 1:47pm
BI's bold 'Unwearable Collection' spotlights rare skin disease
Apr 1, 2022 8:05am
Sun uses the journey as a metaphor in demo exhibition booth
Mar 31, 2022 8:00am
Incyte rolled out 52-week data on Opzelura in vitiligo
Mar 26, 2022 10:40am
AbbVie's Skyrizi bests Cosentyx in head-to-head psoriasis trial
Jun 15, 2020 10:47am
